Search

Author/Creator Kelly, Patrick F

2. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial. Issue 1 (25th May 2022)

Authors:
de la Fuente, Macarena I; Colman, Howard; Rosenthal, Mark; Van Tine, Brian A; Levacic, Danijela; Walbert, Tobias; Gan, Hui K; Vieito, Maria; Milhem, Mohammed M; Lipford, Kathryn; Forsyth, Sanjeev; Guichard, Sylvie M; Mikhailov, Yelena; Sedkov, Alexander; Brevard, Julie; Kelly, Patrick F; Mohamed,...
Journal:
Neuro-oncology
Issue:
Volume 25:Issue 1(2023)
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search